No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Factive market is a subset of the antibiotics market, focusing on the development and production of fluoroquinolone antibiotics. Fluoroquinolones are a class of antibiotics used to treat a wide range of bacterial infections, including respiratory, urinary tract, and skin infections. They are also used to treat some sexually transmitted diseases. Factive is a brand name for the fluoroquinolone antibiotic gemifloxacin, which is used to treat acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia.
Factive is produced by several pharmaceutical companies, including Merck, Daiichi Sankyo, and Teva Pharmaceuticals. Merck is the largest producer of Factive, with a wide range of products available in the United States, Europe, and other countries. Daiichi Sankyo produces Factive in Japan, while Teva Pharmaceuticals produces Factive in Israel. Other companies, such as Pfizer and GlaxoSmithKline, also produce Factive in various countries. Show Less Read more
